Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Hepatitis

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 7 articles: HTML format

Single Articles

October 2025
1. QIU L, Bai S, Cai J, Fang Y, et al
   Antiviral prophylaxis for hepatitis B virus reactivation in T-cell lymphoma patients with resolved hepatitis B virus infection.
   Int J Cancer. 2025 Oct 4. doi: 10.1002/ijc.70186.
   PubMed     Abstract available
   
   
   February 2025
2. CHEN JG, Kensler TW, Zhu J, Zhu YR, et al
   Profound primary prevention of liver cancer following a natural experiment in China: A 50-year perspective and public health implications.
   Int J Cancer. 2025;156:756-763.
   PubMed     Abstract available
   
   
   October 2024
3. LIU J, Zhang X, Lin J, Dai C, et al
   HBcrAg is associated with prognosis of hepatitis B virus-related hepatocellular carcinoma in patients after hepatectomy undergoing antiviral therapy.
   Int J Cancer. 2024 Oct 25. doi: 10.1002/ijc.35224.
   PubMed     Abstract available
   
   
   April 2024
4. KARTSONAKI C, Yao P, Butt J, Jeske R, et al
   Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study.
   Int J Cancer. 2024;154:1423-1432.
   PubMed     Abstract available
   
   
   January 2024
5. ZHAO G, Shi X, Zhang L, Liang H, et al
   Comment on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients".
   Int J Cancer. 2024 Jan 11. doi: 10.1002/ijc.34796.
   PubMed    
   
   
   
6. KIM MN, Zhang X, Ahn SH
   Reply to: Comments on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients".
   Int J Cancer. 2024 Jan 11. doi: 10.1002/ijc.34797.
   PubMed    
   
   
   August 2023
7. HA Y, Lim J, Chon YE, Kim MN, et al
   Five-year on-treatment variables-based PPACS model predicts subsequent hepatocellular carcinoma in entecavir/tenofovir-treated patients.
   Int J Cancer. 2023 Aug 24. doi: 10.1002/ijc.34704.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.